Melexis NV

MELE: XBRU (BEL)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
pscLOCK|&r^y$LOCK|X^fvm!?

Melexis Earnings: Automotive Chip Demand Shows First Signs of Cycle Improvement

In its first-quarter update, Melexis maintained its outlook and expects second-half sales to be higher than the first half. We expect second-half sales to be up 10% sequentially to around EUR 450 million, with any sharper recovery likely happening in 2027.

Sponsor Center